Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

Clinical trial NCT06687837 · RECRUITING

Trial details

NCT number: NCT06687837
Sponsor: Jeffrey S. Schweitzer, MD, PhD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2025-04-29
Primary completion: 2027-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.